Contemporary Trends and Outcomes Associated with the Pre-Procedural Use of Oral P2Y12 Inhibitors in Patients Undergoing Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

OBJECTIVES: We sought to describe trends in the use of pre-procedural P2Y12 inhibitors and their clinical impact in patients undergoing percutaneous coronary intervention (PCI). BACKGROUND: Oral P2Y12 inhibitors are ubiquitously used medications; however, the specific timing of initial P2Y12 inhibit...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Invasive Cardiol
मुख्य लेखकों: Sukul, Devraj, Seth, Milan, Dixon, Simon R., Khandelwal, Akshay, LaLonde, Thomas A., Gurm, Hitinder S.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2017
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5699908/
https://ncbi.nlm.nih.gov/pubmed/28420804
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन